<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurosci</journal-id><journal-title>BMC Neuroscience</journal-title><issn pub-type="epub">1471-2202</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2202-4-23</article-id><article-id pub-id-type="pmid">14505496</article-id><article-id pub-id-type="doi">10.1186/1471-2202-4-23</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Human neuronal stargazin-like proteins, &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4</sub>; an investigation of their specific localization in human brain and their influence on Ca<sub>V</sub>2.1 voltage-dependent calcium channels expressed in <italic>Xenopus </italic>oocytes.</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Moss</surname><given-names>Fraser J</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>fmoss@caltech.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Dolphin</surname><given-names>Annette C</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>a.dolphin@ucl.ac.uk</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Clare</surname><given-names>Jeffrey J</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>jeff.j.clare@gsk.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pharmacology, University College London, Gower Street, London, WC1E 6BT, UK</aff><aff id="I2"><label>2</label>Current address: Division of Biology, M/C 156-29, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125, USA</aff><aff id="I3"><label>3</label>Gene Expression and Protein Biochemistry, GlaxoSmithKline, Medicines Research Center, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK</aff><pub-date pub-type="collection"><year>2003</year></pub-date><pub-date pub-type="epub"><day>23</day><month>9</month><year>2003</year></pub-date><volume>4</volume><fpage>23</fpage><lpage>23</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2202/4/23"/><history><date date-type="received"><day>12</day><month>6</month><year>2003</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2003</year></date></history><copyright-statement>Copyright &#x000a9; 2003 Moss et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement><abstract><sec><title>Background</title><p>Stargazin (&#x003b3;<sub>2</sub>) and the closely related &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>transmembrane proteins are part of a family of proteins that may act as both neuronal voltage-dependent calcium channel (VDCC) &#x003b3; subunits and transmembrane &#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazoleproponinc (AMPA) receptor regulatory proteins (TARPs). In this investigation, we examined the distribution patterns of the stargazin-like proteins &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>in the human central nervous system (CNS). In addition, we investigated whether human &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4 </sub>could modulate the electrophysiological properties of a neuronal VDCC complex transiently expressed in <italic>Xenopus </italic>oocytes.</p></sec><sec><title>Results</title><p>The mRNA encoding human &#x003b3;<sub>2 </sub>is highly expressed in cerebellum, cerebral cortex, hippocampus and thalamus, whereas &#x003b3;<sub>3 </sub>is abundant in cerebral cortex and amygdala and &#x003b3;<sub>4 </sub>in the basal ganglia. Immunohistochemical analysis of the cerebellum determined that both &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>are present in the molecular layer, particularly in Purkinje cell bodies and dendrites, but have an inverse expression pattern to one another in the dentate cerebellar nucleus. They are also detected in the interneurons of the granule cell layer though only &#x003b3;<sub>2 </sub>is clearly detected in granule cells. The hippocampus stains for &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>throughout the layers of the every CA region and the dentate gyrus, whilst &#x003b3;<sub>3 </sub>appears to be localized particularly to the pyramidal and granule cell bodies. When co-expressed in <italic>Xenopus </italic>oocytes with a Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>VDCC complex, either in the absence or presence of an &#x003b1;2&#x003b4;<sub>2 </sub>subunit, neither &#x003b3;<sub>2 </sub>nor &#x003b3;<sub>4 </sub>significantly modulated the VDCC peak current amplitude, voltage-dependence of activation or voltage-dependence of steady-state inactivation.</p></sec><sec><title>Conclusion</title><p>The human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>stargazin-like proteins are detected only in the CNS and display differential distributions among brain regions and several cell types in found in the cerebellum and hippocampus. These distribution patterns closely resemble those reported by other laboratories for the rodent orthologues of each protein. Whilst the fact that neither &#x003b3;<sub>2 </sub>nor &#x003b3;<sub>4 </sub>modulated the properties of a VDCC complex with which they could associate <italic>in vivo </italic>in Purkinje cells adds weight to the hypothesis that the principal role of these proteins is not as auxiliary subunits of VDCCs, it does not exclude the possibility that they play another role in VDCC function.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The mutation underlying the absence epilepsy phenotype of the allelic stargazer (<italic>stg</italic>) and waggler (<italic>wag</italic>) mutant mice occurs in a gene, <italic>cacng2</italic>, whose product, stargazin, has been hypothesized to be a neuronal voltage dependent calcium channel (VDCC) &#x003b3; subunit [<xref ref-type="bibr" rid="B1">1</xref>]. VDCCs are intrinsically involved in the regulation of a multiplicity of Ca<sup>2+ </sup>dependent processes in many different cell types where they are inserted into the plasma membrane as hetero-oligomeric complexes of a pore-forming &#x003b1;<sub>1 </sub>subunit with auxiliary &#x003b2;, &#x003b1;2&#x003b4; and possibly &#x003b3; subunits [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>The first VDCC &#x003b3; subunit to be identified (&#x003b3;<sub>1</sub>) [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>] was found to be solely expressed in skeletal muscle, where its function is to limit calcium entry through the L-type VDCCs of skeletal myotubes [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. VDCCs purified from neuronal tissues did not appear to possess a &#x003b3; subunit [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. However, despite sharing only weak protein sequence identity with &#x003b3;<sub>1 </sub>(25%), stargazin (&#x003b3;<sub>2</sub>) was suggested to represent the first example of a neuronal VDCC &#x003b3; subunit based on its similar tetra-spanning transmembrane structure to the &#x003b3;<sub>1 </sub>subunit and its ability to weakly modulate VDCC-current properties <italic>in vitro </italic>[<xref ref-type="bibr" rid="B1">1</xref>]. Subsequent investigations have identified six other stargazin-like genes which are currently classified as <italic>cacng3</italic>-<italic>cacng8 </italic>(encoding proteins &#x003b3;<sub>3 </sub>- &#x003b3;<sub>8</sub>), in a continuation of the VDCC &#x003b3; subunit nomenclature [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Investigation of the functional influence of these stargazin-like &#x003b3; proteins upon VDCCs has yielded mixed results. Some laboratories have reported that &#x003b3;<sub>2 </sub>and its close homologue &#x003b3;<sub>4 </sub>cause small hyperpolarizing shifts in the voltage dependence of steady-state inactivation [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. This however, might be dependent upon which other auxiliary subunits are co-expressed in the VDCC complex under investigation [<xref ref-type="bibr" rid="B18">18</xref>]. In contrast, Chen et al. [<xref ref-type="bibr" rid="B19">19</xref>] showed whole cell VDCC currents from the cerebellar granule cells of <italic>stg </italic>mice, which effectively lack the &#x003b3;<sub>2 </sub>subunit, do not have significantly altered voltage-dependence of activation or inactivation compared to wild type. Other laboratories reported that &#x003b3;<sub>2 </sub>or &#x003b3;<sub>3 </sub>can significantly reduce peak current amplitudes of N-type VDCCs expressed in <italic>Xenopus </italic>oocytes, but only when co-expressed with an &#x003b1;2&#x003b4;<sub>1 </sub>subunit [<xref ref-type="bibr" rid="B20">20</xref>], and supporting this, that thalamic relay neurons from <italic>stg </italic>mice express enhanced low and high voltage-activated VDCC currents compared to wild type [<xref ref-type="bibr" rid="B21">21</xref>]. Furthermore, clear biochemical evidence has been generated for a direct interaction of &#x003b3;<sub>2 </sub>with the VDCC Ca<sub>V</sub>2.2 &#x003b1;<sub>1 </sub>subunit [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Another stargazin-like protein, &#x003b3;<sub>7</sub>, which is phylogenetically distinct from &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>], almost abolishes the expression of Ca<sub>V</sub>2.2 when co-expressed <italic>in vitro</italic>, and also reduces Ca<sup>2+ </sup>currents via Ca<sub>V</sub>1.2 and Ca<sub>V</sub>2.1 channels [<xref ref-type="bibr" rid="B15">15</xref>]. However, our data indicated that the influence of &#x003b3;<sub>7 </sub>on VDCC function is to reduce &#x003b1;<sub>1 </sub>subunit protein expression, a functional property unlike anything reported for the other stargazin-like proteins, which suggests that &#x003b3;<sub>7 </sub>is not a subunit of a calcium channel complex [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Whilst controversy surrounds the role of the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>stargazin-like proteins in relation to VDCC modulation, a clear function has been determined for these proteins as chaperones for the appropriate trafficking and receptor biogenesis of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. Consequently, these three proteins together with their close homologue &#x003b3;<sub>8</sub>, were recently dubbed transmembrane AMPA receptor regulatory proteins (TARPs) [<xref ref-type="bibr" rid="B25">25</xref>]. A primary interaction (probably via transmembrane and/or extracellular regions [<xref ref-type="bibr" rid="B26">26</xref>]) promotes the trafficking of the GluR subunits to the plasma membrane, and a secondary interaction of the C-terminus of stargazin with PSD-95 or a similar cytoskeletal protein via a PSD-95/DLG/ZO-1(PDZ)-binding motif facilitates the lateral relocation of the glutamate receptor complex to its correct position in the post-synaptic density [<xref ref-type="bibr" rid="B19">19</xref>] and hence influences the number of AMPA receptors located at this site [<xref ref-type="bibr" rid="B27">27</xref>].</p><p>Elucidation of the differential distribution of the stargazin-like proteins coupled with studies of the physiological abnormalities underlying the epilepsy phenotypes of the mice expressing what are effectively null mutations of &#x003b3;<sub>2 </sub>has also helped to determine some of the normal functions of these proteins in the murine CNS. The <italic>stg </italic>and <italic>wag </italic>mice display a loss of the fast component of EPSC at mossy fiber to cerebellar granule cell synapses [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>], plus reduced synaptic transmission at parallel fiber Purkinje cell synapses in <italic>wag </italic>[<xref ref-type="bibr" rid="B29">29</xref>]. However, the synaptic transmission to CA1 pyramidal cells (Schaffer collateral projection) in <italic>stg </italic>is not altered [<xref ref-type="bibr" rid="B28">28</xref>]. <italic>In situ </italic>hybridization studies have determined that murine &#x003b3;<sub>2 </sub>is normally expressed at its highest levels in the cerebellum [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>mRNAs are also detected in mouse cerebellum but &#x003b3;<sub>3 </sub>mRNA has been detected only in the Golgi neurons of the granule cell layer and is absent from the molecular layer [<xref ref-type="bibr" rid="B19">19</xref>]. &#x003b3;<sub>4 </sub>mRNA is localized to the Purkinje, rather than the granule cell layer [<xref ref-type="bibr" rid="B14">14</xref>]. Whilst this manuscript was in preparation, Tomita et al. [<xref ref-type="bibr" rid="B25">25</xref>] reported that &#x003b3;<sub>2 </sub>is the only TARP expressed in rat cerebellar granule cells, but like mouse, all isoforms are detected in hippocampus [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The genetic defect in <italic>stg </italic>results in the loss of &#x003b3;<sub>2 </sub>mRNA and protein and does not appear to result in up- or down-regulated expression of &#x003b3;<sub>3 </sub>or &#x003b3;<sub>4 </sub>[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Collectively, these data suggest that <italic>stg </italic>mice exhibit the loss of fast synaptic transmission in the mossy fiber to granule cell synapse because &#x003b3;<sub>2 </sub>is the major and possibly the only stargazin-like protein in the cerebellar granule cells of wild-type mice and no other stargazin-like protein is expressed at sufficient levels to rescue normal AMPA receptor trafficking and maturation. The reason that synaptic transmission to CA1 pyramidal cells in <italic>stg </italic>mice is preserved is probably because, although &#x003b3;<sub>2 </sub>is not expressed in <italic>stg</italic>, the total remaining TARP expression levels in hippocampal CA1 pyramidal cells are adequate to promote normal surface expression of mature AMPA receptors at the postsynaptic membrane in this synapse.</p><p>It was therefore of great interest to examine whether the expression patterns of the human stargazin-like proteins paralleled those of mouse and if they were differentially expressed in the various cell types of each tissue. This study presents the differential distribution of &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>in human brain by northern blotting and more detailed immunohistochemical analysis of their expression in human cerebellum and hippocampus. In addition, we used the results of our distribution study to investigate whether the human &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>could modulate currents gated by a VDCC complex heterologously expressed in <italic>Xenopus </italic>oocytes that was assembled from the major VDCC subunits expressed in a cerebellar Purkinje cell.</p></sec><sec><title>Results</title><sec><title>Northern Blot analysis of mRNA distribution</title><p>The overall tissue distribution of human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>mRNAs was analyzed by northern blotting. Specific cDNA probes representing each gene were generated as described in the methods and hybridized against a human multiple-tissue northern blot (Figure <xref ref-type="fig" rid="F1">1A</xref>) and two brain region blots (Figure <xref ref-type="fig" rid="F1">1B</xref> and <xref ref-type="fig" rid="F1">1C</xref>). The &#x003b3;<sub>2</sub>-specific cDNA probe detected two mRNAs of approximately 7 kb and 3 kb. Bands of similar size were reported in a mouse multiple-tissue blot probed with a murine &#x003b3;<sub>2 </sub>cDNA probe [<xref ref-type="bibr" rid="B1">1</xref>]. Like mouse, the human &#x003b3;<sub>2 </sub>mRNA transcripts were detected only in brain (Figure <xref ref-type="fig" rid="F1">1A</xref>), and were particularly abundant in cerebellum, cerebral cortex, occipital lobe, frontal lobe and temporal lobe, hippocampus and thalamus (Figure <xref ref-type="fig" rid="F1">1B</xref> and <xref ref-type="fig" rid="F1">1C</xref>). &#x003b3;<sub>2 </sub>transcripts were detected at somewhat lower levels in medulla, putamen, amygdala and substantia nigra but only weakly in caudate nucleus. &#x003b3;<sub>2 </sub>transcripts were absent from corpus callosum and the sub-thalamic nucleus and spinal cord.</p><p>A &#x003b3;<sub>3 </sub>cDNA probe detected one 2.0&#x02013;2.1 kb &#x003b3;<sub>3 </sub>mRNA transcript which like &#x003b3;<sub>2</sub>, was exclusively localized to the brain (Figure <xref ref-type="fig" rid="F1">1A</xref>). However, &#x003b3;<sub>3 </sub>mRNA was detected only in cerebral cortex, including occipital lobe, frontal lobe, and temporal lobe, the putamen, caudate nucleus, amygdala and hippocampus and was absent from all of the other regions probed (Figure <xref ref-type="fig" rid="F1">1B</xref> and <xref ref-type="fig" rid="F1">1C</xref>).</p><p>The &#x003b3;<sub>4</sub>-specific probe identified an mRNA of approximately 4 kb detected exclusively in brain (Figure <xref ref-type="fig" rid="F1">1A</xref>). This was widely detected throughout the brain but was most prevalent in the putamen and caudate nucleus. Unlike &#x003b3;<sub>2 </sub>or &#x003b3;<sub>3</sub>, &#x003b3;<sub>4 </sub>mRNA was also weakly detected in spinal cord.</p></sec><sec><title>Generation and characterization of &#x003b3; specific antisera</title><p>In order to investigate the distribution of the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>proteins and to analyze their expression in different neuronal cell types we generated specific antisera against each isoform. These were generated using peptide immunogens that were selected to be subtype-specific as determined by multiple sequence alignment. To confirm activity against the corresponding holopeptide and lack of cross-reactivity with the other subtypes, each of these antisera were validated against the different subunit proteins recombinantly expressed in COS-7 cells. Cells were transiently transfected with a pMT2 expression vector containing either the human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>or &#x003b3;<sub>4 </sub>cDNAs, and 2&#x02013;3 days later were analyzed by immunocytochemistry. All three &#x003b3; isoforms could be readily detected and were localized largely in the plasma membrane of the cells (Figure <xref ref-type="fig" rid="F2">2A</xref>). The specificity of the antibodies (Abs) was confirmed by incubating non-transfected cells with each primary Ab, which in each case gave no immunoreactivity (Figure <xref ref-type="fig" rid="F2">2B</xref>). Similar results were obtained when cells expressing one of the &#x003b3; isoforms were incubated with Abs directed against either of the other two &#x003b3; proteins (data not shown). Cells transfected with a &#x003b3; cDNA but which were not permeablized after fixation also exhibited no immunoreactivity (Figure <xref ref-type="fig" rid="F2">2C</xref>). Since the peptide sequences chosen for immunization are in the C-terminus, these results indicate this portion of recombinantly expressed &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>is located intracellularly. Co-transfection of VDCC subunits Ca<sub>V</sub>2.1 and &#x003b2;<sub>4 </sub>did not alter the expression pattern of the &#x003b3; proteins indicating that there are no effects on trafficking and that the anti-&#x003b3; Abs did not cross-react with the Ca<sub>V</sub>2.1 or &#x003b2;<sub>4 </sub>subunits (data not shown).</p></sec><sec><title>Immunolocalization of &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>in human cerebellum and hippocampus</title><p>Immunohistochemical analysis was carried out to examine the differential expression of &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>in human cerebellum and hippocampus. Control experiments to measure non-specific binding to tissue sections were performed by pre-absorbing antisera overnight with 100 &#x003bc;M of the relevant peptide (Figures <xref ref-type="fig" rid="F3">3E</xref> and <xref ref-type="fig" rid="F3">3I</xref>, <xref ref-type="fig" rid="F4">4C</xref> and <xref ref-type="fig" rid="F4">4D</xref>, <xref ref-type="fig" rid="F5">5C</xref> and <xref ref-type="fig" rid="F5">5D</xref> and <xref ref-type="fig" rid="F6">6B</xref>) and by omitting the primary antibody (data not shown).</p></sec><sec><title>Cerebellum</title><p>Figure <xref ref-type="fig" rid="F3">3</xref> shows the pattern of staining observed in the cerebellum using &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>specific antisera. Moderate &#x003b3;<sub>2</sub>-specific staining was seen in the molecular layer suggesting expression in the dendrites of cerebellar Purkinje neurons (Figure <xref ref-type="fig" rid="F3">3A</xref>). Small cell bodies in the molecular layer that were most likely stellate or basket cell interneurons also stained positively. The &#x003b3;<sub>2 </sub>immunostaining was also strong in the soma of Purkinje neurons extending to the dendrites, but decreasing in intensity following the first few bifurcations (Figure <xref ref-type="fig" rid="F3">3A</xref>). Cerebellar granule cells were moderately stained for &#x003b3;<sub>2 </sub>(Figure <xref ref-type="fig" rid="F3">3B</xref>), although assessment of immunostaining in this cell type was difficult since the majority of cell volume is comprised of the nucleus. The strongest &#x003b3;<sub>2 </sub>immunostaining in this region was actually in the interneurons. Figure <xref ref-type="fig" rid="F3">3C</xref> shows strong &#x003b3;<sub>2 </sub>immunostaining in the cell bodies of the dentate cerebellar nucleus with only weak to moderate staining in the surrounding neuropil.</p><p>Very weak &#x003b3;<sub>3 </sub>staining was observed in Purkinje cell bodies and in the interneurons of the granule cell layer (Figure <xref ref-type="fig" rid="F3">3D</xref>). Staining of the molecular layer neuropil and the granule cells is comparable to the peptide pre-absorption control (Figure <xref ref-type="fig" rid="F3">3E</xref>). It is therefore possible that the &#x003b3;<sub>3 </sub>protein is poorly represented in these particular cell types and not completely absent from the cerebellum. No &#x003b3;<sub>3 </sub>immunoreactivity was observed in the dentate cerebellar nucleus (data not shown).</p><p>Staining of a human cerebellar folium for &#x003b3;<sub>4 </sub>is shown in Figure <xref ref-type="fig" rid="F3">3F</xref>. The molecular layer and adjacent granule cell layer was lightly to moderately stained, but the staining of the Purkinje cell bodies and dendrites was striking. &#x003b3;<sub>4 </sub>immunostaining extended well into the Purkinje cell dendritic arbors from the cell body indicating that &#x003b3;<sub>4 </sub>expressed well throughout this cell type. The cell bodies that stained positively in the molecular layer were small interneurons. In the granule cell layer the interneurons stained strongly for &#x003b3;<sub>4 </sub>whereas the granule cells appear unstained (Figure <xref ref-type="fig" rid="F3">3G</xref>). In the dentate cerebellar nucleus (Figure <xref ref-type="fig" rid="F3">3H</xref>), &#x003b3;<sub>4 </sub>immunostaining was detected strongly in the perisomatic neuropil with only weak staining in the cell bodies. Interestingly, this staining pattern was almost the complete inverse of the &#x003b3;<sub>2 </sub>immunostaining in the same region (Figure <xref ref-type="fig" rid="F3">3C</xref>).</p></sec><sec><title>Hippocampus and dentate gyrus</title><p>Immunohistochemistry revealed differential expression patterns for &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>in the different regions and cell types of human hippocampus and dentate gyrus (Figure <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="fig" rid="F6">6</xref>). When incubated with the anti-&#x003b3;<sub>2 </sub>Ab, generalized staining of the cell layers and neuropil throughout the hippocampal formation was observed. In Figure <xref ref-type="fig" rid="F4">4A</xref> the alveus, stratum oriens most adjacent to the CA1 pyramidal layer, and the pyramidal layer all stained moderately for &#x003b3;<sub>2</sub>. The stratum radiatum and lacunosum-moleculare stained much more weakly. The CA2 and CA3 pyramidal layers stain well for the &#x003b3;<sub>2 </sub>subunit (Figure <xref ref-type="fig" rid="F4">4B</xref>) and the intensity of staining in the alveus increased slightly in this region. It is however apparent that there is only a very weak staining of the strata oriens and radiatum in the CA2/3 regions; yet, moderate immunostaining is detected in the stratum lucidum. Weak staining is visible in the stratum lacunosum-moleculare. In the same section we also observed moderate &#x003b3;<sub>2 </sub>staining in the molecular layer of the dentate gyrus and strong immunostaining in the granule cells (examined at higher magnification on Figure <xref ref-type="fig" rid="F4">4H</xref>). The &#x003b3;<sub>2 </sub>staining was weak or absent in the polymorphic layer, but distinct fibers were stained which course across this region. Moderate staining of cell bodies in CA4 was also observed (Figure <xref ref-type="fig" rid="F4">4B</xref>, top left portion of the panel). Pre-absorption controls using the &#x003b3;<sub>2 </sub>peptide immunogen (Figures <xref ref-type="fig" rid="F4">4C</xref> and <xref ref-type="fig" rid="F4">4D</xref>) show the background staining in a serial section of the same hippocampus as in Figures <xref ref-type="fig" rid="F4">4A</xref> and <xref ref-type="fig" rid="F4">4B</xref>. The perisomatic staining in the stratum pyramidale, in the region of the CA1 towards the CA2 was moderate, with slightly more intense somatic staining (Figure <xref ref-type="fig" rid="F4">4E</xref>). An apparently higher level of &#x003b3;<sub>2 </sub>staining in the CA2 and CA3 regions (Figures <xref ref-type="fig" rid="F4">4F</xref> and <xref ref-type="fig" rid="F4">4G</xref>) compared to CA1 was probably due to a higher density of pyramidal cell soma in these regions compared to the CA1 region [<xref ref-type="bibr" rid="B30">30</xref>].</p><p>Staining for &#x003b3;<sub>3 </sub>was absent from the alveus, stratum oriens, stratum radiatum and lacunosum-moleculare, but the pyramidal layer of the CA1, CA2 and CA3 regions of Ammon's horn strained strongly, with lesser immunostaining in the subiculum and CA4 regions (Figure <xref ref-type="fig" rid="F5">5A</xref> and <xref ref-type="fig" rid="F5">5B</xref>). Closer examination revealed that the pyramidal cell bodies stained strongly for &#x003b3;<sub>3 </sub>and this staining was strongest in CA3 and became progressively weaker through the CA2 and CA1 regions and into the subiculum. High power images of CA1 (Figure <xref ref-type="fig" rid="F5">5E</xref>), CA3 (Figure <xref ref-type="fig" rid="F5">5F</xref>), and subiculum (Figure <xref ref-type="fig" rid="F5">5G</xref>) determined that this was most likely to be caused by increased cell densities in the CA2/3 regions rather than more intense staining of pyramidal neurons, although perisomatic staining was more intense in the CA3 region than CA1, and absent from the subiculum. Visible in Figure <xref ref-type="fig" rid="F5">5A</xref> and <xref ref-type="fig" rid="F5">5B</xref>, and also observed at an increased magnification in Figure <xref ref-type="fig" rid="F5">5H</xref>, the granule layer of the dentate gyrus is distinctly labeled whereas the molecular and polymorphic layers display weak or no immunostaining. The granule cells stained moderately to strongly for &#x003b3;<sub>3 </sub>and the immunoreactivity was mainly in the soma of these cells, but could also be seen in the early branches of the granule cell dendritic trees, which extend into the lightly stained molecular layer (Figure <xref ref-type="fig" rid="F5">5H</xref>).</p><p>At the macroscopic level, medium to strong &#x003b3;<sub>4 </sub>immunostaining was seen throughout the pyramidal layers of Ammon's horn and in the alveus (Figure <xref ref-type="fig" rid="F6">6A</xref>). The alveus stained strongly for &#x003b3;<sub>4 </sub>as did the cell bodies in the pyramidal layer of all CA regions. This was observed more clearly at high power with a similar high level of staining of pyramidal cell bodies throughout the CA1-4 regions, but with the most intense perisomatic staining observed in the CA2/3 region (Figure, <xref ref-type="fig" rid="F6">6C, 6D</xref>, and <xref ref-type="fig" rid="F6">6E</xref>). Weak to moderate staining was observed throughout the neuropil of the strata surrounding the pyramidal layers in all regions. In the dentate gyrus, the granule cell layer appears to stain slightly more strongly than the adjacent molecular or polymorphic regions (Figure <xref ref-type="fig" rid="F6">6F</xref>). This also may be an artifact of the cell density in the granule layer rather than increased expression of the &#x003b3;<sub>4 </sub>protein in the dentate granule cell bodies compared to their processes.</p></sec><sec><title>The effects of &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>on the biophysical properties of Ca<sub>V</sub>2.1 calcium channels</title><p>Since the role of the stargazin-like proteins in relation to VDCC function remains controversial we examined the effects of &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>on the biophysical properties of Ca<sub>V</sub>2.1 calcium channels. Together with the Ca<sub>V</sub>2.1 &#x003b1; subunit, we co-expressed a &#x003b2;<sub>4 </sub>subunit with or without an &#x003b1;2&#x003b4;<sub>2 </sub>subunit. These VDCC subunits are known to be highly expressed in cerebellar Purkinje cells [<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B38">38</xref>], a cell type that, according to the immunohistochemistry data presented herein, strongly expresses both &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4</sub>. Figure <xref ref-type="fig" rid="F7">7A</xref> and <xref ref-type="fig" rid="F7">7B</xref> show the current-voltage relations of Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>and Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>VDCCs respectively, expressed in <italic>Xenopus </italic>oocytes either in the presence or absence of &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4</sub>. Neither &#x003b3;<sub>2 </sub>nor &#x003b3;<sub>4 </sub>produced a statistically significant shift in the half-maximal voltage of activation (V<sub>50act</sub>) of Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>(Table <xref ref-type="table" rid="T1">1</xref>). The slope factor (k<sub>act</sub>), maximum conductance (G<sub>max</sub>), and peak current amplitude at +10 mV were also very similar to controls on co-expression of either &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4 </sub>in the absence the &#x003b1;2&#x003b4;<sub>2 </sub>subunit. Co-expression of the &#x003b1;2&#x003b4;<sub>2 </sub>subunit was sufficient to significantly increase the G<sub>max </sub>and peak current amplitude of a Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>Ca<sup>2+ </sup>channel complex (Figure <xref ref-type="fig" rid="F7">7A</xref> and <xref ref-type="fig" rid="F7">7B</xref>). However, the increase was not affected by the additional co-expression of either &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4</sub>.</p><p>No statistically significant differences were observed in the half-maximal voltage of steady-state inactivation (V<sub>50inact</sub>) or slope factor (k<sub>inact</sub>) of Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>or Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>VDCCs co-expressing &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4 </sub>(Figure <xref ref-type="fig" rid="F7">7C</xref>, <xref ref-type="fig" rid="F7">7D</xref> and <xref ref-type="fig" rid="F7">7E</xref> and Table <xref ref-type="table" rid="T2">2</xref>).</p></sec></sec><sec><title>Discussion</title><sec><title>Differential distribution of human stargazin-like &#x003b3; mRNAs</title><p>The northern blot analysis described herein detected the human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>mRNAs only in the brain. Similar mRNA distributions and transcript sizes have been reported by <italic>in situ </italic>hybridization and northern blot for the mouse orthologues [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B19">19</xref>] and these data are supported by western blots [<xref ref-type="bibr" rid="B22">22</xref>]. We do not however rule out the possibility that human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>may be expressed in some non-CNS tissues that are not included on the multiple tissue northern blot used in this study. Other laboratories that employed highly sensitive reverse-transcriptase polymerase chain reaction expression analyses have reported that &#x003b3;<sub>4 </sub>in particular is expressed in some non-neuronal tissues [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. The &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>transcripts were detected in most of the brain regions probed and mainly in the same tissues. However, in some regions where both isoforms are detected, for example the cerebellum or thalamus, &#x003b3;<sub>2 </sub>expression is higher than &#x003b3;<sub>4</sub>, whereas in the basal ganglia regions of putamen and caudate nucleus &#x003b3;<sub>4 </sub>mRNA is the more highly represented transcript. &#x003b3;<sub>3 </sub>is much more selectively detected, but its expression is coincident with both &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>in all regions in which it was detected by northern blot.</p><p>An additional observation was that these stargazin-like &#x003b3; proteins are differentially detected in some of the nuclei that comprise the basal ganglia, a region believed to be involved in the planning and programming of movement, or more broadly in the processes by which intention is converted into voluntary action. The putamen has a heterogeneous neuronal &#x003b3; population with &#x003b3;<sub>4 </sub>mRNA possibly the most prevalent of the three &#x003b3; transcripts investigated herein, as has been previously observed in both mouse and rat brain [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The caudate nucleus also expresses transcripts for all three stargazin-like &#x003b3; proteins, however the signal detected with the &#x003b3;<sub>2 </sub>probe was extremely weak in comparison to those for &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4</sub>. On the other hand, &#x003b3;<sub>2 </sub>was the most prevalent species detected in substantia nigra, with faint detection of &#x003b3;<sub>4 </sub>and no &#x003b3;<sub>3 </sub>signal. No signals for any of the &#x003b3; transcripts were detected in the sub-thalamic nucleus. Further immunohistochemical and electrophysiological investigation will be required to elucidate why &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>have such differential distributions in these nuclei.</p></sec><sec><title>In vitro expression of human stargazin-like proteins and antibody specificity</title><p>The transient expression of cloned human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>cDNAs in COS-7 cells served several purposes: It determined that the human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>cDNA clones expressed <italic>in vitro</italic>; it demonstrated the specificity of three anti-&#x003b3; Abs, one generated to detect each of the three isoforms; it revealed that the stargazin-like &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>all localize to the plasma membrane of COS-7 cells when expressed either alone or in combination with other VDCC subunits and finally it showed that COS-7 cells do not endogenously express &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>or &#x003b3;<sub>4</sub>. Furthermore, because the anti-&#x003b3; Abs, all of which were designed to detect epitopes in the C-terminus after the fourth predicted transmembrane segment, failed to stain COS-7 cells that had not been permeablized, it was established that the C-terminus is localized to the membrane and inside the cell. If predictions of secondary structure as envisaged by other laboratories are correct, a tetra-spanning transmembrane conformation will also place the N-terminus on the cytoplasmic side of the membrane [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B16">16</xref>].</p></sec><sec><title>The distribution of the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>in cerebellum</title><p>This study is the first immunohistochemical analysis of stargazin-like &#x003b3; proteins in the human CNS. In the cerebellum, we observed that &#x003b3;<sub>2 </sub>was detected in molecular, granule and Purkinje cell layers as has been previously reported for mouse &#x003b3;<sub>2 </sub>protein [<xref ref-type="bibr" rid="B22">22</xref>] and mRNA [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. A major difference between human and rodent immunostaining patterns was observed for &#x003b3;<sub>4</sub>, which was detected as very high levels in human cerebellar Purkinje cell bodies and processes, an observation not reported for rat or mouse [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The detection of &#x003b3;<sub>3 </sub>protein expression in the human cerebellum, albeit at extremely low levels, was similar to the &#x003b3;<sub>3 </sub>mRNA detection patterns reported in mouse or rat cerebellum [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>] but disagree with the findings on our northern blots and the <italic>in situ </italic>hybridization data of Klugbauer et al. [<xref ref-type="bibr" rid="B14">14</xref>]. The positive, albeit weak detection of &#x003b3;<sub>3 </sub>protein in cerebellar interneurons and low levels detected in Purkinje cell bodies suggests that &#x003b3;<sub>3 </sub>is expressed in distinct types of neurons in human cerebellum at levels too low to be detected by some hybridization conditions.</p><p>The almost inverse staining patterns of &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>in the dentate cerebellar nucleus (DCN) was striking. Much of the perisomatic neuropil surrounding the DCN somata consists of afferents from the Purkinje cells and is stained particularly strongly for &#x003b3;<sub>4 </sub>while the DCN cell bodies stained strongly for &#x003b3;<sub>2 </sub>but were devoid of &#x003b3;<sub>4 </sub>staining. It is therefore a reasonable assumption that &#x003b3;<sub>4 </sub>is pre-synaptically localized in the Purkinje cell afferents to the DCN whilst &#x003b3;<sub>2 </sub>localizes to the post-synaptic regions of the DCN cell bodies. Indeed this observation holds with the finding that &#x003b3;<sub>4 </sub>expressed well throughout Purkinje cell processes. &#x003b3;<sub>4 </sub>also appears to be localized in the GABAergic neurons of the cerebellum more than the excitatory glutamatergic cell types. In addition to showing strong immunostaining throughout Purkinje cells, &#x003b3;<sub>4 </sub>is detected in the interneurons of the molecular layer and also the Golgi interneurons of the granule layer. Whilst &#x003b3;<sub>2 </sub>is also detected in all these cell types, the &#x003b3;<sub>4 </sub>immunostaining is noticeably lower, if not absent from the excitatory granule cells, and is absent from the DCN cell bodies.</p></sec><sec><title>The distribution of &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>in hippocampus</title><p>This study has determined that &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>show differential but overlapping expression patterns in the human hippocampus and dentate gyrus. As is the case for the cerebellum, the expression patterns of &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>more closely resemble one another than that of &#x003b3;<sub>3</sub>. The &#x003b3;<sub>2</sub>, and &#x003b3;<sub>4 </sub>proteins were detected throughout the hippocampus and dentate gyrus, although there were variations in the staining of cell bodies, dendrites and neuropil in the different sub-fields. &#x003b3;<sub>3 </sub>localized more specifically in the neuronal cell bodies of the hippocampus and dentate gyrus. This possibly indicates that &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>are involved in synaptic modulation of neurotransmission throughout the cell, whereas &#x003b3;<sub>3 </sub>is solely involved in functions such as regulation of VDCCs or AMPA receptors in the cell soma.</p></sec><sec><title>Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>VDCC currents are not modulated by human &#x003b3;<sub>2</sub> or &#x003b3;<sub>4 </sub>co-expression in the presence or absence of an &#x003b1;2&#x003b4;<sub>2 </sub>subunit</title><p>The co-expression of &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4 </sub>with Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>VDCCs in the absence or presence of the &#x003b1;2&#x003b4;<sub>2 </sub>subunit, did not significantly affect peak current amplitude or any of the activation or inactivation properties. These data agree closely with the findings of Chen et al. [<xref ref-type="bibr" rid="B19">19</xref>] who recorded whole cell Ca<sup>2+ </sup>currents from <italic>stg </italic>and wild type cerebellar granule cells. They reported that absence of &#x003b3;<sub>2 </sub>neither altered the I-V relationship of the native whole cell Ca<sup>2+ </sup>current nor did it significantly modulate the steady-state inactivation properties of VDCC current compared to wild type. Although they did not use pharmacological agents to isolate specific components of the whole cell Ca<sup>2+ </sup>current which might have highlighted subtle changes particular to the P/Q-, N-, R-, or L-type currents present in this cell type [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>], it is unlikely that another known &#x003b3; isoform could functionally substitute for &#x003b3;<sub>2 </sub>to maintain normal VDCC function in that instance because distribution studies have shown that they are probably not expressed in this cell type [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. This indicated that even if &#x003b3;<sub>2 </sub>was associated directly or indirectly with a VDCC complex in cerebellar granule cells [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>], it did not modulate the high voltage activated VDCC I-V relationship or inactivation properties.</p><p>More recent patch clamp recordings from <italic>stg </italic>thalamic relay neurons showed a 45% increase in HVA VDCC peak current densities compared to wild type [<xref ref-type="bibr" rid="B21">21</xref>] consistent with a previous report that &#x003b3;<sub>2 </sub>inhibited high voltage activated VDCC peak current amplitude by 37&#x02013;40% when expressed in <italic>Xenopus </italic>oocytes [<xref ref-type="bibr" rid="B20">20</xref>]. Why our data and those of Chen <italic>et al</italic>. [<xref ref-type="bibr" rid="B19">19</xref>] are so different from these results may be explained by differences in subunit combinations expressed in granule cells and thalamic relay neurons and between the two <italic>in vitro </italic>studies. Stargazin-like proteins might be able to directly modulate VDCC complexes consisting of particular subunit combinations, but are unable to reproduce this influence on other subunit complexes if they required additional interacting proteins not present in the <italic>Xenopus </italic>oocyte or cerebellar granule cells. The electrophysiological data therefore cannot be used as a strong argument to warrant considering these &#x003b3; proteins as an integral part of high voltage-activated Ca<sup>2+ </sup>channels because modulation of current properties has not been reproducible between different studies. Nevertheless, there is biochemical evidence for the association of &#x003b3;<sub>2 </sub>and &#x003b3;<sub>3 </sub>with the N-type Ca<sub>V</sub>2.2 channel [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>] and it is quite possible that whilst &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>readily associate with certain neuronal VDCC complexes, specific environmental conditions must be met for them to exert a measurable biophysical influence.</p></sec></sec><sec><title>Conclusions</title><p>Human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>stargazin-like proteins (or TARPs) are detected solely in the CNS. On the whole, their differential distributions closely parallel those of their rodent orthologues as observed by northern blot, <italic>in situ </italic>hybridization, western blot and immunohistochemistry [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>] with some notable exceptions. The differential expression pattern of each isoform among the cell types present in human cerebellum and hippocampus predicts specific roles for each subtype in neuronal function, and possibly even segregated VDCC-&#x003b3; or AMPA receptor-&#x003b3; complexes [<xref ref-type="bibr" rid="B25">25</xref>]. The results of our electrophysiology experiments support the notion that &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>stargazin-like proteins are not "subunits" of VDCCs in the true sense of the word. Nevertheless, we do not discount the possibility that they may interact with VDCCs and possibly influence trafficking, assembly or integration of VDCCs and AMPA-receptor function in their native environment or that to modulate VDCC current they require other factors not endogenously expressed in <italic>Xenopus </italic>oocytes.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>cDNA sources and synthesis</title><p>Human brain total RNA was purchased from Invitrogen (Paisley, UK) and used to generate cDNA using the Superscript Pre-amplification System (Invitrogen) primed with random hexamers according to the manufacturer's instructions.</p></sec><sec><title>Isolation and cloning of the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>cDNAs</title><p>The complete open reading frame (ORF) of human <italic>CACNG2 </italic>cDNA was amplified from 25 ng human brain cDNA by PCR (cycling parameters: 98&#x000b0;C for 1 min, then 30 cycles of 98&#x000b0;C for 30 s, 55&#x000b0;C for 30 s, 72&#x000b0;C for 2 min, followed by a final 10 min extension step at 72&#x000b0;C) containing Pfu polymerase and 25 pmol each of the gene specific primers (GSPs), 5'-GCGGCCGCACCATGGGGCTGTTTGATC-3' and 5'-GCTAGCCTCGAGTTAGTGTTTATATAATGAAGAA-3'. These amplify the ORF of <italic>CACNG2</italic>, with a 5' extension of a <italic>Not </italic>I restriction site and partial Kozak sequence for initiation of translation in vertebrates (ACC) [<xref ref-type="bibr" rid="B41">41</xref>] and a 3' extension of <italic>Xho </italic>I and <italic>Nhe </italic>I restriction enzyme sites. Amplified fragments of the correct size were purified from agarose gels using the Qiaex II kit (Qiagen, Crawley, UK), and cloned into pCR2.1-TOPO vector (Invitrogen). Positive colonies identified by blue/white screening were confirmed by <italic>EcoR </italic>I restriction digest of purified plasmid and were sequenced on both strands using T7 (5'-TAATACGACTCACTAT AGGG-3') and M13R (5'-CAGGAAACAGCTATGAC-3') universal primers and gene specific primers in an automated dye terminator sequencer (Applied Biosystems, Warrington, UK).</p><p>The same procedures used to clone human <italic>CACNG2 </italic>were followed to clone <italic>CACNG3 </italic>and <italic>CACNG4</italic>, but using the primer pairs, 5'-CGGCCGCCACCATGAGGATGTGTGACAGAGGTA-3' and 5'-GCTAGCCTCGAGTCAGTTCAGACGGGCGTGG TG-3' to amplify <italic>CACNG3 </italic>ORF or, 5'-GCGGCCGCACCATGGTGCGATGCGACCGCG-3' and 5'-GCTAGCCTCGAGTCACACAGGGGTCGTCCGTC-3' to amplify <italic>CACNG4 </italic>ORF. These primer pairs contained the same restriction enzyme sites and if appropriate, the partial Kozak sequence [<xref ref-type="bibr" rid="B41">41</xref>] in their 5' extensions as were included in the <italic>CACNG2 </italic>primers. The human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>cDNAs were subcloned into the pMT2 vector for expression in <italic>Xenopus </italic>oocytes and COS-7 cells [<xref ref-type="bibr" rid="B42">42</xref>].</p></sec><sec><title>Other cDNA clones</title><p>The following cDNAs were used: rabbit Ca<sub>V</sub>2.1 (X57689), rat &#x003b2;<sub>4 </sub>(LO2315) and mouse &#x003b1;2&#x003b4;<sub>2 </sub>(AF247139, common brain splice variant). All cDNAs were subcloned into expression vector pMT2 [<xref ref-type="bibr" rid="B42">42</xref>].</p></sec><sec><title>Antibodies</title><p>Multiple sequence alignments and basic local alignment search tool (BLAST) searches compared the protein sequences of all known stargazin-like &#x003b3; proteins with one another and with other proteins in the public databases. This identified regions of lowest homology between &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>that were not present in any other known proteins. The following peptides, TARATDYLQASAITRIPS (&#x003b3;<sub>2</sub>, amino acids 211&#x02013;228), FHNSTPKEFKESLHNNPAN (&#x003b3;<sub>3</sub>, amino acids 291&#x02013;309) and VHDFFQQDLKEGFHVSMLN (&#x003b3;<sub>4</sub>, amino acids 303&#x02013;321), were synthesized by standard solid-phase techniques at Severn Biotech (Kidderminster, UK) to generate specific polyclonal antibodies (Abs). Each was coupled to the carrier protein tuberculin purified protein derivative (PPD) using sulpho- Succinimidyl4- [N-maleimidomethyl] cyclohexane-1-carboxylate (SMCC) (Pierce, Tattenhall, UK) via a Cys residue added at the N-terminus during synthesis. To raise polyclonal anti-&#x003b3;<sub>2</sub>, anti-&#x003b3;<sub>3 </sub>and anti-&#x003b3;<sub>4 </sub>Abs, the resulting conjugates were used to immunize Bacille Calmette-Guerin (BCG)-sensitized Dutch rabbits at monthly intervals [<xref ref-type="bibr" rid="B43">43</xref>]. The immune response was monitored by indirect enzyme-linked immunoabsorbent assay (ELISA) with free peptide-coated micro-titer plates. Immunoglobulins from the terminal bleeds were purified using immobilized peptide antigen columns (Sulfo-link, Pierce). Each anti-&#x003b3; Ab was checked for specificity for its target by immunocytochemistry. COS-7 cells transfected with a single stargazin-like &#x003b3; protein cDNA were examined for positive staining following incubation with the appropriate affinity purified Ab. Control slides were also examined for cross-reaction of the primary Ab with non-transfected COS-7 cells, stargazin-like &#x003b3; proteins other than the target against which the primary Ab was intended to bind (data not shown) and the VDCC &#x003b1;<sub>1</sub>, &#x003b1;2&#x003b4;, and &#x003b2; subunits used in this investigation. Finally, positive staining of target protein was abolished following overnight pre-incubation (at 4&#x000b0;C) of the primary Ab with a 10 &#x000d7; molar excess of the peptide against which it was raised (data not shown).</p></sec><sec><title>Cell culture and transfections</title><p>COS-7 cell were cultured as previously described [<xref ref-type="bibr" rid="B44">44</xref>]. Transfection was performed using the Geneporter transfection reagent (Gene Therapy Systems, San Diego, CA). Cells were plated onto coverslips 2&#x02013;3 h prior to transfection. The DNA and Geneporter reagent (2 &#x003bc;g and 10 &#x003bc;l, respectively) were each diluted in 500 &#x003bc;l of serum-free medium, mixed, and applied to the cells. The &#x003b1;<sub>1</sub>, &#x003b2;, &#x003b1;2&#x003b4; and &#x003b3; cDNAs were mixed and transfected in a 1:1:1:1 ratio by DNA weight. If a particular cDNA was absent from the transfection, substitution with blank pMT2 vector maintained correct subunit ratios. After 3.5 h, 1 ml of medium containing 20% serum was added to the cells, which were then incubated at 37&#x000b0;C for 3 days. Prior to staining, cells were re-plated using a non-enzymatic cell dissociation solution (Sigma, Dorset, UK) and maintained at 27&#x000b0;C for between 2 and 6 h.</p></sec><sec><title>Immunocytochemistry</title><p>COS-7 cells were fixed and permeablized for immunocytochemistry essentially as previously described [<xref ref-type="bibr" rid="B44">44</xref>]. Primary Abs, affinity purified anti-&#x003b3;<sub>2</sub>, anti-&#x003b3;<sub>3 </sub>and anti-&#x003b3;<sub>4 </sub>were used at 0.2 &#x003bc;g/ml. Secondary biotin conjugated or goat anti-rabbit (Sigma, Dorset, UK) Ab was applied at 5 &#x003bc;g/ml. Texas red-conjugated streptavidin was applied at 3.3 &#x003bc;g/ml. The nuclear dye 4', 6-diamidino-2-phenylindole (DAPI, 300 nM, Molecular Probes) was also used to visualize the nucleus. Cells were examined on a confocal scanning laser microscope (Leica TCS SP, Milton Keynes, UK). All images were scanned sequentially to eliminate cross-talk and photomultiplier settings kept constant in each experiment.</p></sec><sec><title>Northern blots</title><p>Human 12-lane multiple tissue blots and brain II and III blots (BD Biosciences Clontech) were hybridized at 65&#x000b0; C in ExpressHyb solution (BD Biosciences Clontech) according to the manufacturer's instructions. The [&#x003b1;<sup>32</sup>P] radiolabeled &#x003b3; probes corresponding to nucleotides 597&#x02013;814, 560&#x02013;792 or 594&#x02013;804 of the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>or &#x003b3;<sub>4 </sub>ORFs respectively, were assembled according to the Strip-EZ DNA Probe Synthesis Removal Kit (Ambion (Europe) Ltd, Huntingdon, UK). The final stringency wash performed was 0.1 &#x000d7; Saline Sodium Citrate, 0.1% Sodium dodecylsulphate (SDS) at 65&#x000b0;C.</p></sec><sec><title>Human Brain Immunohistochemistry</title><p>Human brain tissue was obtained from two males aged 76 and 80 years whose causes of death were listed as metastatic carcinoma and left ventricular failure respectively. No prior history of brain disease was noted. The tissue, provided by the Cambridge Brain Bank Laboratory at the University of Cambridge, U.K., was collected using ethical consent procedures according to U.K. law. Sections were fixed in neutral buffered formalin and processed to paraffin wax. Paraffin-embedded wax blocks were sectioned on a Microm HM3555S microtome at 7 &#x003bc;m and underwent a microwave antigen retrieval procedure using a citrate buffer at pH 6.0 prior to immunostaining [<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>]. Endogenous peroxidase was blocked with 3% hydrogen peroxide in water followed by non-specific protein blocking in 5% milk powder in phosphate buffered saline (PBS). Sections were incubated overnight with primary Ab (anti-&#x003b3;<sub>2</sub>, 0.85 &#x003bc;g/ml; anti-&#x003b3;<sub>3</sub>, 1.3 &#x003bc;g/ml; anti-&#x003b3;<sub>4</sub>, 0.85 &#x003bc;g/ml) diluted with 3% goat serum and 0.1% Triton X-100 at 4&#x000b0;C in a moist chamber. Treatment of all sections post application of primary Ab was identical. Goat anti-rabbit (1:20 dilution, Biogenex, Wokingham, UK) link Ab was applied to all sections and incubated at room temperature for 20 min, followed by horseradish peroxidase-conjugated streptavidin (Biogenex, prediluted (1/20)) that was incubated for a further 20 min. Sections were visualized using 3,3'-diaminobenzidine (DAB) solution made up according to Vector kit SK-4100 (Peterborough, UK), and incubated with the sections for 2&#x02013;10 min. In a few cases, sections were counterstained briefly in Mayer's hematoxylin prior to microscopic examination.</p><p>Negative control preparations performed in all immunohistochemistry experiments included replacement of primary antibodies with PBS only and preincubation of primary antibodies with the 100 &#x003bc;M corresponding immunizing peptide overnight at 4&#x000b0;C prior to immunostaining.</p></sec><sec><title>Microscopy and image analysis</title><p>Slides were analyzed using a Zeiss Axioplan Optical Microscope (Carl Zeiss Ltd., Welwyn Garden City, UK). All sections were viewed under bright-field illumination using &#x000d7; 2.5, &#x000d7; 10, &#x000d7; 20, or &#x000d7; 40 objectives and a stabilized light source. For each tissue section, both The Central Nervous System [<xref ref-type="bibr" rid="B47">47</xref>], and The Human Brain: an introduction to its functional anatomy [<xref ref-type="bibr" rid="B48">48</xref>] were used for reference, together with corresponding counterstained sections to locate and define nuclear groups. A JVC KY-F55B television camera attached to the microscope and a PC running AcQuis image capture software (Syncroscopy, Cambridge, UK) was used to obtain images of each section.</p></sec><sec><title>Electrophysiology</title><p>Adult female <italic>Xenopus laevis </italic>were killed by anesthetic overdose in a 0.25% solution of tricaine, decapitated, and pithed. Oocytes were removed and defolliculated by treatment with 2 mg/ml collagenase type IA in Ca<sup>2+</sup>-free ND96 saline containing (in mM): NaCl, 96; KCl, 2; MgCl<sub>2</sub>, 1; and HEPES, 5, pH-adjusted to 7.4 with NaOH for 2 hr at 21&#x000b0;C. Plasmid cDNAs for the different VDCC subunits were mixed in a weight ratio of 1:1:1:1, and ~10 nl was injected into the nuclei of stage V or VI oocytes. In control oocytes without a &#x003b3; cDNA or in the absence of an &#x003b1;2&#x003b4; cDNA, an equal volume of water was substituted in the mix. Injected oocytes were incubated at 18&#x000b0;C for 3&#x02013;5 days in ND96 saline (as above plus 1.8 mM CaCl<sub>2</sub>) supplemented with 100 &#x003bc;g/ml penicillin, 100 IU/ml streptomycin (Invitrogen), and 2.5 mM Na pyruvate. Whole-cell recordings from oocytes were made in the two-electrode voltage-clamp configuration under continuous gravity-fed superfusion (~1 ml/min) with a chloride-free solution containing (in mM): Ba(OH)<sub>2</sub>, 10; TEA-OH, 80; NaOH, 25; CsOH, 2; and HEPES, 5 (pH7.4 with methanesulfonic acid). In all experiments, oocytes were injected with 30&#x02013;40 nl of a 100 mM solution of K3-1, 2-bis (aminophenoxy) ethane-N, N, N', N'-tetra-acetic acid (BAPTA) in order to suppress endogenous Ca<sup>2+</sup>-activated Cl<sup>- </sup>currents. Recording microelectrodes, were pulled from thick-walled borosilicate glass capillary tubing with the following dimensions: 1.5 mm outer diameter, 1.0 mm bore diameter and with an internal 0.1 mm fiber (Plowden and Thompson, Stourbridge, UK). The TEVC pipettes were pulled using a P-87 Flaming/Brown microelectrode puller (Sutter Instrument Company, Novato, CA). Electrodes contained 3M KCl and had resistances of 0.3&#x02013;2 M&#x003a9;. The holding potential (V<sub>H</sub>) was -100 mV. Membrane currents were recorded, amplified, low-pass filtered at 1 kHz using a Geneclamp 500 B amplifier, digitized through a Digidata 1200 interface (Axon Instruments, Foster City, CA) and stored on a PC using data acquisition software pClamp 6.02 (Axon Instruments). In all cases currents were leak subtracted on-line by a P/4 protocol. Additional analyses including calculation of means, standard error of the mean (S. E. M.), significance (unpaired Student's <italic>t</italic>-tests, where applicable) and curve fitting were calculated using Origin 5.0 (OriginLab Corporation, Northampton, MA). One-way analysis of variance (ANOVA) and post-hoc tests were performed using software available at <ext-link ext-link-type="uri" xlink:href="http://faculty.vassar.edu/lowry/VassarStats.htm"/>. Where mean values are presented they are shown as mean &#x000b1; S. E. M. (with <italic>n </italic>depicting the number of oocytes from which the mean was calculated). Statistical significance was defined as P &#x0003c; 0. 05.</p><p>Current-voltage (I-V) relation curves generated from currents activated by a 200 ms long depolarizing pulse were fitted with a combined Boltzmann and linear fit function:</p><p>I = G<sub>max </sub>(V - V<sub>rev</sub>) / (1 + exp(- (V - V<sub>50act</sub>) / k)) </p><p>where I is the whole cell current amplitude, G<sub>max </sub>is the maximum slope conductance, V<sub>0.5act </sub>is voltage of the mid-point of activation, V<sub>rev </sub>is the reversal potential and k is the slope factor for activation.</p><p>Steady-state inactivation data were generated from currents activated by a 100 ms long depolarizing pulse from the holding potential (V<sub>H</sub>) to 0 mV immediately after a 25 s conditioning pre-pulse between -100 and 0 mV. Current amplitudes were normalized to the maximum amplitude and fitted with a Boltzmann function of the form:</p><p>I / I<sub>max </sub>= 1 / (1 + exp((V - V<sub>50inact</sub>) / k)) </p><p>where I / I<sub>max </sub>is the normalized peak current, V<sub>50inact </sub>is the voltage for the mid-point of inactivation, V is the conditioning voltage and k is the slope factor for inactivation.</p></sec></sec><sec><title>Authors' contributions</title><p>FJM carried out the cloning of the human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3 </sub>and &#x003b3;<sub>4 </sub>proteins, performed all the necessary practical and analytical procedures to acquire and process the primary data presented in this paper and drafted the manuscript. ACD and JJC participated in the conception, design and coordination of the study. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The Medical Research Council as part of an industrial collaborative PhD studentship with GlaxoSmithKline supported F. J. M. The Wellcome Trust provided additional support. The authors would like to thank Dr M. Rees (University College London) for the &#x003b1;2&#x003b4;<sub>2 </sub>cDNA and acknowledge the assistance of Dr. Carles Cant&#x000ec; (University College London), and Dr. Chris Plumpton, Michael Hurle and Margaret Flint (GlaxoSmithKline, Stevenage, UK).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Letts</surname><given-names>VA</given-names></name><name><surname>Felix</surname><given-names>R</given-names></name><name><surname>Biddlecome</surname><given-names>GH</given-names></name><name><surname>Arikkath</surname><given-names>J</given-names></name><name><surname>Mahaffey</surname><given-names>CL</given-names></name><name><surname>Valenzuela</surname><given-names>A</given-names></name><name><surname>Bartlett</surname><given-names>F. S., 2nd</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name></person-group><article-title>The mouse stargazer gene encodes a neuronal Ca<sup>2</sup>+channel &#x003b3; subunit</article-title><source>Nat Genet</source><year>1998</year><volume>19</volume><fpage>340</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">9697694</pub-id><pub-id pub-id-type="doi">10.1038/1228</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><article-title>Structure and regulation of voltage-gated Ca<sup>2+</sup> channels</article-title><source>Annu Rev Cell Dev Biol</source><year>2000</year><volume>16</volume><fpage>521</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">11031246</pub-id><pub-id pub-id-type="doi">10.1146/annurev.cellbio.16.1.521</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname><given-names>SD</given-names></name><name><surname>Ellis</surname><given-names>SB</given-names></name><name><surname>McCue</surname><given-names>AF</given-names></name><name><surname>Williams</surname><given-names>ME</given-names></name><name><surname>Vedvick</surname><given-names>TS</given-names></name><name><surname>Harpold</surname><given-names>MM</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><article-title>Primary structure of the &#x003b3; subunit of the DHP-sensitive calcium channel from skeletal muscle</article-title><source>Science</source><year>1990</year><volume>248</volume><fpage>490</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">2158672</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>PA</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Hogan</surname><given-names>K</given-names></name><name><surname>Gregg</surname><given-names>RG</given-names></name></person-group><article-title>Molecular characterization of the gene encoding the &#x003b3; subunit of the human skeletal muscle 1,4-dihydropyridine-sensitive Ca<sup>2+</sup> channel (CACNLG), cDNA sequence, gene structure, and chromosomal location</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>9275</fpage><lpage>9279</lpage><pub-id pub-id-type="pmid">8387489</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosse</surname><given-names>E</given-names></name><name><surname>Regulla</surname><given-names>S</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name><name><surname>Ruth</surname><given-names>P</given-names></name><name><surname>Meyer</surname><given-names>HE</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name></person-group><article-title>The cDNA and deduced amino acid sequence of the &#x003b3; subunit of the L-type calcium channel from rabbit skeletal muscle</article-title><source>FEBS Lett</source><year>1990</year><volume>267</volume><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">2163895</pub-id><pub-id pub-id-type="doi">10.1016/0014-5793(90)80312-7</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahern</surname><given-names>CA</given-names></name><name><surname>Powers</surname><given-names>PA</given-names></name><name><surname>Biddlecome</surname><given-names>GH</given-names></name><name><surname>Roethe</surname><given-names>L</given-names></name><name><surname>Vallejo</surname><given-names>P</given-names></name><name><surname>Mortenson</surname><given-names>L</given-names></name><name><surname>Strube</surname><given-names>C</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name><name><surname>Coronado</surname><given-names>R</given-names></name><name><surname>Gregg</surname><given-names>RG</given-names></name></person-group><article-title>Modulation of L-type Ca<sup>2+</sup> current but not activation of Ca<sup>2+</sup> release by the gamma1 subunit of the dihydropyridine receptor of skeletal muscle</article-title><source>BMC Physiol</source><year>2001</year><volume>1</volume><fpage>8</fpage><pub-id pub-id-type="pmid">11495636</pub-id><pub-id pub-id-type="doi">10.1186/1472-6793-1-8</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freise</surname><given-names>D</given-names></name><name><surname>Held</surname><given-names>B</given-names></name><name><surname>Wissenbach</surname><given-names>U</given-names></name><name><surname>Pfeifer</surname><given-names>A</given-names></name><name><surname>Trost</surname><given-names>C</given-names></name><name><surname>Himmerkus</surname><given-names>N</given-names></name><name><surname>Schweig</surname><given-names>U</given-names></name><name><surname>Freichel</surname><given-names>M</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Hoth</surname><given-names>M</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name></person-group><article-title>Absence of the &#x003b3; subunit of the skeletal muscle dihydropyridine receptor increases L-type Ca<sup>2+</sup> currents and alters channel inactivation properties</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>14476</fpage><lpage>14481</lpage><pub-id pub-id-type="pmid">10799530</pub-id><pub-id pub-id-type="doi">10.1074/jbc.275.19.14476</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McEnery</surname><given-names>MW</given-names></name><name><surname>Snowman</surname><given-names>AM</given-names></name><name><surname>Sharp</surname><given-names>AH</given-names></name><name><surname>Adams</surname><given-names>ME</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><article-title>Purified omega-conotoxin GVIA receptor of rat brain resembles a dihydropyridine-sensitive L-type calcium channel</article-title><source>Proc Natl Acad Sci U S A</source><year>1991</year><volume>88</volume><fpage>11095</fpage><lpage>11099</lpage><pub-id pub-id-type="pmid">1662383</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahlijanian</surname><given-names>MK</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><article-title>Subunit structure and localization of dihydropyridine-sensitive calcium channels in mammalian brain, spinal cord, and retina</article-title><source>Neuron</source><year>1990</year><volume>4</volume><fpage>819</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">2163262</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>De Waard</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>VE</given-names></name><name><surname>Gurnett</surname><given-names>CA</given-names></name><name><surname>Lennon</surname><given-names>VA</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><article-title>Identification of three subunits of the high affinity &#x003c9;-conotoxin MVIIC-sensitive Ca<sup>2+</sup> channel</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>13804</fpage><lpage>13810</lpage><pub-id pub-id-type="pmid">8662888</pub-id><pub-id pub-id-type="doi">10.1074/jbc.271.23.13804</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin-Moutot</surname><given-names>N</given-names></name><name><surname>Leveque</surname><given-names>C</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>R</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Seagar</surname><given-names>M</given-names></name></person-group><article-title>Properties of &#x003c9; conotoxin MVIIC receptors associated with &#x003b1;1A calcium channel subunits in rat brain</article-title><source>FEBS Lett</source><year>1995</year><volume>366</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">7789508</pub-id><pub-id pub-id-type="doi">10.1016/0014-5793(95)00467-N</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>J. L., 3rd</given-names></name><name><surname>Lennon</surname><given-names>VA</given-names></name></person-group><article-title>Identification and cloning of putative human neuronal voltage-gated calcium channel &#x003b3;-2 and &#x003b3;-3 subunits: neurologic implications</article-title><source>Mayo Clin Proc</source><year>1999</year><volume>74</volume><fpage>357</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">10221464</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>PJ</given-names></name><name><surname>Robertson</surname><given-names>HM</given-names></name><name><surname>Best</surname><given-names>PM</given-names></name></person-group><article-title>Calcium channel &#x003b3; subunits provide insights into the evolution of this gene family</article-title><source>Gene</source><year>2001</year><volume>280</volume><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">11738816</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(01)00738-7</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klugbauer</surname><given-names>N</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Specht</surname><given-names>V</given-names></name><name><surname>Lacinova</surname><given-names>L</given-names></name><name><surname>Marais</surname><given-names>E</given-names></name><name><surname>Bohn</surname><given-names>G</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name></person-group><article-title>A family of &#x003b3;-like calcium channel subunits</article-title><source>FEBS Lett</source><year>2000</year><volume>470</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">10734232</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(00)01306-5</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>FJ</given-names></name><name><surname>Viard</surname><given-names>P</given-names></name><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Bertaso</surname><given-names>F</given-names></name><name><surname>Page</surname><given-names>KM</given-names></name><name><surname>Graham</surname><given-names>A</given-names></name><name><surname>Canti</surname><given-names>C</given-names></name><name><surname>Plumpton</surname><given-names>M</given-names></name><name><surname>Plumpton</surname><given-names>C</given-names></name><name><surname>Clare</surname><given-names>JJ</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group><article-title>The novel product of a five-exon stargazin-related gene abolishes Ca<sub>V</sub>2.2 calcium channel expression</article-title><source>Embo J</source><year>2002</year><volume>21</volume><fpage>1514</fpage><lpage>1523</lpage><pub-id pub-id-type="pmid">11927536</pub-id><pub-id pub-id-type="doi">10.1093/emboj/21.7.1514</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>DL</given-names></name><name><surname>Davis</surname><given-names>CF</given-names></name><name><surname>Gefrides</surname><given-names>LA</given-names></name><name><surname>Noebels</surname><given-names>JL</given-names></name></person-group><article-title>Identification of three novel Ca<sup>2+</sup> channel &#x003b3; subunit genes reveals molecular diversification by tandem and chromosome duplication</article-title><source>Genome Res</source><year>1999</year><volume>9</volume><fpage>1204</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">10613843</pub-id><pub-id pub-id-type="doi">10.1101/gr.9.12.1204</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>DL</given-names></name><name><surname>Gefrides</surname><given-names>LA</given-names></name><name><surname>Foreman</surname><given-names>PJ</given-names></name><name><surname>Noebels</surname><given-names>JL</given-names></name></person-group><article-title>A cluster of three novel Ca<sup>2+</sup> channel &#x003b3; subunit genes on chromosome 19q13.4: evolution and expression profile of the &#x003b3; subunit gene family</article-title><source>Genomics</source><year>2001</year><volume>71</volume><fpage>339</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">11170751</pub-id><pub-id pub-id-type="doi">10.1006/geno.2000.6440</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rousset</surname><given-names>M</given-names></name><name><surname>Cens</surname><given-names>T</given-names></name><name><surname>Restituito</surname><given-names>S</given-names></name><name><surname>Barrere</surname><given-names>C</given-names></name><name><surname>Black</surname><given-names>J. L., 3rd</given-names></name><name><surname>McEnery</surname><given-names>MW</given-names></name><name><surname>Charnet</surname><given-names>P</given-names></name></person-group><article-title>Functional roles of &#x003b3;2, &#x003b3;3 and &#x003b3;4, three new Ca<sup>2+</sup> channel subunits, in P/Q-type Ca<sup>2+</sup> channel expressed in Xenopus oocytes</article-title><source>J Physiol</source><year>2001</year><volume>532</volume><fpage>583</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">11313431</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chetkovich</surname><given-names>DM</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Sweeney</surname><given-names>NT</given-names></name><name><surname>Kawasaki</surname><given-names>Y</given-names></name><name><surname>Wenthold</surname><given-names>RJ</given-names></name><name><surname>Bredt</surname><given-names>DS</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><article-title>Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>936</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">11140673</pub-id><pub-id pub-id-type="doi">10.1038/35046031</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>MG</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Felix</surname><given-names>R</given-names></name><name><surname>Letts</surname><given-names>VA</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><article-title>Biochemical and biophysical evidence for &#x003b3;2 subunit association with neuronal voltage-activated Ca<sup>2+</sup> channels</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>32917</fpage><lpage>32924</lpage><pub-id pub-id-type="pmid">11441000</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M100787200</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Yi</given-names></name><name><surname>Mori</surname><given-names>Mayra</given-names></name><name><surname>Burgess</surname><given-names>Daniel L.</given-names></name><name><surname>Noebels</surname><given-names>Jeffrey L.</given-names></name></person-group><article-title>Mutations in High-Voltage-Activated Calcium Channel Genes Stimulate Low-Voltage-Activated Currents in Mouse Thalamic Relay Neurons</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>6362</fpage><lpage>6371</lpage><pub-id pub-id-type="pmid">12151514</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>AH</given-names></name><name><surname>Black</surname><given-names>J. L., 3rd</given-names></name><name><surname>Dubel</surname><given-names>SJ</given-names></name><name><surname>Sundarraj</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>JP</given-names></name><name><surname>Yunker</surname><given-names>AM</given-names></name><name><surname>Copeland</surname><given-names>TD</given-names></name><name><surname>McEnery</surname><given-names>MW</given-names></name></person-group><article-title>Biochemical and anatomical evidence for specialized voltage-dependent calcium channel &#x003b3; isoform expression in the epileptic and ataxic mouse, stargazer</article-title><source>Neuroscience</source><year>2001</year><volume>105</volume><fpage>599</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">11516827</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(01)00220-2</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chetkovich</surname><given-names>Dane M.</given-names></name><name><surname>Chen</surname><given-names>Lu</given-names></name><name><surname>Stocker</surname><given-names>Timothy J.</given-names></name><name><surname>Nicoll</surname><given-names>Roger A.</given-names></name><name><surname>Bredt</surname><given-names>David S.</given-names></name></person-group><article-title>Phosphorylation of the Postsynaptic Density-95 (PSD-95)/Discs Large/Zona Occludens-1 Binding Site of Stargazin Regulates Binding to PSD-95 and Synaptic Targeting of AMPA Receptors</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>5791</fpage><lpage>5796</lpage><pub-id pub-id-type="pmid">12122038</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Ko</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name></person-group><article-title>Phosphorylation of stargazin by protein kinase A regulates its interaction with PSD-95</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>12359</fpage><lpage>12363</lpage><pub-id pub-id-type="pmid">11805122</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M200528200</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname><given-names>Susumu</given-names></name><name><surname>Chen</surname><given-names>Lu</given-names></name><name><surname>Kawasaki</surname><given-names>Yoshimi</given-names></name><name><surname>Petralia</surname><given-names>Ronald S.</given-names></name><name><surname>Wenthold</surname><given-names>Robert J.</given-names></name><name><surname>Nicoll</surname><given-names>Roger A.</given-names></name><name><surname>Bredt</surname><given-names>David S.</given-names></name></person-group><article-title>Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins</article-title><source>J Cell Biol</source><year>2003</year><volume>161</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">12771129</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200212116</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arikkath</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Ahern</surname><given-names>C</given-names></name><name><surname>Allamand</surname><given-names>V</given-names></name><name><surname>Flanagan</surname><given-names>JD</given-names></name><name><surname>Coronado</surname><given-names>R</given-names></name><name><surname>Gregg</surname><given-names>RG</given-names></name><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group><article-title>&#x003b3;1 subunit interactions within the skeletal muscle L-type voltage-gated calcium channels</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>1212</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">12409298</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M208689200</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schnell</surname><given-names>Eric</given-names></name><name><surname>Sizemore</surname><given-names>Max</given-names></name><name><surname>Karimzadegan</surname><given-names>Siavash</given-names></name><name><surname>Chen</surname><given-names>Lu</given-names></name><name><surname>Bredt</surname><given-names>David S.</given-names></name><name><surname>Nicoll</surname><given-names>Roger A.</given-names></name></person-group><article-title>Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number</article-title><source>PNAS</source><year>2002</year><volume>99</volume><fpage>13902</fpage><lpage>13907</lpage><pub-id pub-id-type="pmid">12359873</pub-id><pub-id pub-id-type="doi">10.1073/pnas.172511199</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Fukaya</surname><given-names>M</given-names></name><name><surname>Qiao</surname><given-names>X</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Kano</surname><given-names>M</given-names></name></person-group><article-title>Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>6027</fpage><lpage>6036</lpage><pub-id pub-id-type="pmid">10407040</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>S</given-names></name><name><surname>Qiao</surname><given-names>X</given-names></name><name><surname>Thompson</surname><given-names>RF</given-names></name></person-group><article-title>Impaired cerebellar synapse maturation in waggler, a mutant mouse with a disrupted neuronal calcium channel &#x003b3; subunit</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>12132</fpage><lpage>12137</lpage><pub-id pub-id-type="pmid">10518588</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.21.12132</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mouritzen Dam</surname><given-names>A</given-names></name></person-group><article-title>The density of neurons in the human hippocampus</article-title><source>Neuropathol Appl Neurobiol</source><year>1979</year><volume>5</volume><fpage>249</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">481699</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Volsen</surname><given-names>SG</given-names></name><name><surname>Day</surname><given-names>NC</given-names></name><name><surname>McCormack</surname><given-names>AL</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Craig</surname><given-names>PJ</given-names></name><name><surname>Beattie</surname><given-names>R</given-names></name><name><surname>Ince</surname><given-names>PG</given-names></name><name><surname>Shaw</surname><given-names>PJ</given-names></name><name><surname>Ellis</surname><given-names>SB</given-names></name><name><surname>Gillespie</surname><given-names>A</given-names></name><collab>et al.</collab></person-group><article-title>The expression of neuronal voltage-dependent calcium channels in human cerebellum</article-title><source>Brain Res Mol Brain Res</source><year>1995</year><volume>34</volume><fpage>271</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">8750830</pub-id><pub-id pub-id-type="doi">10.1016/0169-328X(95)00234-J</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Volsen</surname><given-names>SG</given-names></name><name><surname>Day</surname><given-names>NC</given-names></name><name><surname>McCormack</surname><given-names>AL</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Craig</surname><given-names>PJ</given-names></name><name><surname>Beattie</surname><given-names>RE</given-names></name><name><surname>Smith</surname><given-names>D</given-names></name><name><surname>Ince</surname><given-names>PG</given-names></name><name><surname>Shaw</surname><given-names>PJ</given-names></name><name><surname>Ellis</surname><given-names>SB</given-names></name><name><surname>Mayne</surname><given-names>N</given-names></name><name><surname>Burnett</surname><given-names>JP</given-names></name><name><surname>Gillespie</surname><given-names>A</given-names></name><name><surname>Harpold</surname><given-names>MM</given-names></name></person-group><article-title>The expression of voltage-dependent calcium channel &#x003b2; subunits in human cerebellum</article-title><source>Neuroscience</source><year>1997</year><volume>80</volume><fpage>161</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">9252229</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(97)00115-2</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>PJ</given-names></name><name><surname>McAinsh</surname><given-names>AD</given-names></name><name><surname>McCormack</surname><given-names>AL</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Beattie</surname><given-names>RE</given-names></name><name><surname>Priestley</surname><given-names>JV</given-names></name><name><surname>Yip</surname><given-names>JL</given-names></name><name><surname>Averill</surname><given-names>S</given-names></name><name><surname>Longbottom</surname><given-names>ER</given-names></name><name><surname>Volsen</surname><given-names>SG</given-names></name></person-group><article-title>Distribution of the voltage-dependent calcium channel &#x003b1;<sub>1A</sub> subunit throughout the mature rat brain and its relationship to neurotransmitter pathways</article-title><source>J Comp Neurol</source><year>1998</year><volume>397</volume><fpage>251</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">9658287</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19980727)397:2&#x0003c;251::AID-CNE7&#x0003e;3.3.CO;2-M</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westenbroek</surname><given-names>RE</given-names></name><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Elliott</surname><given-names>EM</given-names></name><name><surname>Hell</surname><given-names>JW</given-names></name><name><surname>Starr</surname><given-names>TV</given-names></name><name><surname>Snutch</surname><given-names>TP</given-names></name><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><article-title>Immunochemical identification and subcellular distribution of the &#x003b1;1A subunits of brain calcium channels</article-title><source>J Neurosci</source><year>1995</year><volume>15</volume><fpage>6403</fpage><lpage>6418</lpage><pub-id pub-id-type="pmid">7472404</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>O</given-names></name><name><surname>Sakagami</surname><given-names>H</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name></person-group><article-title>Localization of mRNAs of voltage-dependent Ca<sup>2+</sup>channels: four subtypes of &#x003b1;1- and &#x003b2;-subunits in developing and mature rat brain</article-title><source>Brain Res Mol Brain Res</source><year>1995</year><volume>30</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">7609630</pub-id><pub-id pub-id-type="doi">10.1016/0169-328X(94)00265-G</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stea</surname><given-names>A</given-names></name><name><surname>Tomlinson</surname><given-names>WJ</given-names></name><name><surname>Soong</surname><given-names>TW</given-names></name><name><surname>Bourinet</surname><given-names>E</given-names></name><name><surname>Dubel</surname><given-names>SJ</given-names></name><name><surname>Vincent</surname><given-names>SR</given-names></name><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group><article-title>Localization and functional properties of a rat brain &#x003b1;1A calcium channel reflect similarities to neuronal Q- and P-type channels</article-title><source>Proc Natl Acad Sci U S A</source><year>1994</year><volume>91</volume><fpage>10576</fpage><lpage>10580</lpage><pub-id pub-id-type="pmid">7524096</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hobom</surname><given-names>M</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>Marais</surname><given-names>E</given-names></name><name><surname>Lacinova</surname><given-names>L</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Klugbauer</surname><given-names>N</given-names></name></person-group><article-title>Neuronal distribution and functional characterization of the calcium channel &#x003b1;-2 subunit</article-title><source>Eur J Neurosci</source><year>2000</year><volume>12</volume><fpage>1217</fpage><lpage>1226</lpage><pub-id pub-id-type="pmid">10762351</pub-id><pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.01009.x</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barclay</surname><given-names>J</given-names></name><name><surname>Balaguero</surname><given-names>N</given-names></name><name><surname>Mione</surname><given-names>M</given-names></name><name><surname>Ackerman</surname><given-names>SL</given-names></name><name><surname>Letts</surname><given-names>VA</given-names></name><name><surname>Brodbeck</surname><given-names>J</given-names></name><name><surname>Canti</surname><given-names>C</given-names></name><name><surname>Meir</surname><given-names>A</given-names></name><name><surname>Page</surname><given-names>KM</given-names></name><name><surname>Kusumi</surname><given-names>K</given-names></name><name><surname>Perez-Reyes</surname><given-names>E</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name><name><surname>Gardiner</surname><given-names>RM</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name><name><surname>Rees</surname><given-names>M</given-names></name></person-group><article-title>Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>6095</fpage><lpage>6104</lpage><pub-id pub-id-type="pmid">11487633</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname><given-names>A</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Pharmacological dissection of multiple types of Ca<sup>2+</sup> channel currents in rat cerebellar granule neurons</article-title><source>J Neurosci</source><year>1995</year><volume>15</volume><fpage>2995</fpage><lpage>3012</lpage><pub-id pub-id-type="pmid">7722641</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>HA</given-names></name><name><surname>Sutton</surname><given-names>KG</given-names></name><name><surname>Scott</surname><given-names>RH</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group><article-title>Characterization of Ca<sup>2+</sup> channel currents in cultured rat cerebellar granule neurones</article-title><source>J Physiol</source><year>1995</year><volume>482 ( Pt 3)</volume><fpage>493</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">7738844</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozak</surname><given-names>M</given-names></name></person-group><article-title>An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs</article-title><source>Nucleic Acids Res</source><year>1987</year><volume>15</volume><fpage>8125</fpage><lpage>8148</lpage><pub-id pub-id-type="pmid">3313277</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swick</surname><given-names>AG</given-names></name><name><surname>Janicot</surname><given-names>M</given-names></name><name><surname>Cheneval-Kastelic</surname><given-names>T</given-names></name><name><surname>McLenithan</surname><given-names>JC</given-names></name><name><surname>Lane</surname><given-names>MD</given-names></name></person-group><article-title>Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes</article-title><source>Proc Natl Acad Sci U S A</source><year>1992</year><volume>89</volume><fpage>1812</fpage><lpage>1816</lpage><pub-id pub-id-type="pmid">1542676</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lachmann</surname><given-names>PJ</given-names></name><name><surname>Strangeways</surname><given-names>L</given-names></name><name><surname>Vyakarnam</surname><given-names>A</given-names></name><name><surname>Evan</surname><given-names>G</given-names></name></person-group><article-title>Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals</article-title><source>Ciba Found Symp</source><year>1986</year><volume>119</volume><fpage>25</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">3015516</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brice</surname><given-names>NL</given-names></name><name><surname>Berrow</surname><given-names>NS</given-names></name><name><surname>Campbell</surname><given-names>V</given-names></name><name><surname>Page</surname><given-names>KM</given-names></name><name><surname>Brickley</surname><given-names>K</given-names></name><name><surname>Tedder</surname><given-names>I</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group><article-title>Importance of the different &#x003b2; subunits in the membrane expression of the &#x003b1;1A and &#x003b1;2 calcium channel subunits: studies using a depolarization-sensitive &#x003b1;1A antibody</article-title><source>Eur J Neurosci</source><year>1997</year><volume>9</volume><fpage>749</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">9153581</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKee</surname><given-names>PH</given-names></name><name><surname>Hobbs</surname><given-names>C</given-names></name><name><surname>Hall</surname><given-names>PA</given-names></name></person-group><article-title>Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds</article-title><source>Histopathology</source><year>1993</year><volume>23</volume><fpage>377</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">8300073</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>SR</given-names></name><name><surname>Key</surname><given-names>ME</given-names></name><name><surname>Kalra</surname><given-names>KL</given-names></name></person-group><article-title>Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections</article-title><source>J Histochem Cytochem</source><year>1991</year><volume>39</volume><fpage>741</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">1709656</pub-id></citation></ref><ref id="B47"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Brodal</surname><given-names>Per</given-names></name></person-group><source>The Central Nervous System</source><year>1998</year><edition>2nd</edition><publisher-name>Oxford, Oxford University Press</publisher-name></citation></ref><ref id="B48"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Nolte</surname><given-names>J</given-names></name></person-group><source>The Human Brain: an introduction to its functional anatomy</source><year>2001</year><edition>5th</edition><publisher-name>London, Mosby</publisher-name></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Northern blot analysis of the human &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>mRNA transcripts. </bold><bold>A. </bold>Human multiple-tissue northern blots revealed that the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>are exclusively detected in the brain. <bold>B &#x00026; C</bold>. Brain region blots determined that the &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>are almost ubiquitously expressed, but at differential levels in the same tissues. &#x003b3;<sub>3 </sub>is more specifically localized to cerebral cortex, amygdala, caudate nucleus and hippocampus. Size markers were from an RNA ladder provided on the blot by BD Biosciences Clontech and the &#x003b2;-actin control probe results are displayed in the bottom panels.</p></caption><graphic xlink:href="1471-2202-4-23-1"></graphic></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Transient expression of &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>in COS-7 cells. </bold><bold>A</bold>. Positive staining for &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, or &#x003b3;<sub>4 </sub>(red) is strongly localized to the membranes of permeablized cells transfected with the individual &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, or &#x003b3;<sub>4 </sub>cDNAs. Little immunostaining is observed in the cytoplasm between the membrane and nucleus (blue). <bold>B. </bold>Non-transfected cells did not stain for &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, or &#x003b3;<sub>4 </sub>using the Abs generated in this study. <bold>C</bold>. Cells transfected with &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, or &#x003b3;<sub>4 </sub>cDNA, but not permeablized during the staining process do not show immunoreactivity for the appropriate anti-&#x003b3; Abs. <bold>D</bold>. When co-transfected together with the Ca<sub>V</sub>2.1 and &#x003b2;<sub>4 </sub>VDCC subunit cDNAs, the expression patterns of &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, or &#x003b3;<sub>4 </sub>were unaltered. Scale bars in all panels represent 10 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-4-23-2"></graphic></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Expression of the &#x003b3;<sub>2</sub>, &#x003b3;<sub>3</sub>, and &#x003b3;<sub>4 </sub>stargazin-like proteins in human cerebellum. </bold><bold>A. </bold>&#x003b3;<sub>2 </sub>immunoreactivity in the molecular layer (<bold>m</bold>) and part of the adjacent granule cell layer (<bold>g</bold>) in a cerebellar folium. Strong &#x003b3;<sub>2</sub> immunostaining was seen in the Purkinje cell somata (<bold>p</bold>) that continued into the dendrites, observed as moderate staining of the molecular layer neuropil. Cell bodies in the molecular layer with positive &#x003b3;<sub>2</sub> immunoreactivity are small interneurons (<bold>i</bold>). <bold>B. </bold>In the granule cell layer, the granule cells (<bold>g</bold>) are moderately stained for &#x003b3;<sub>2 </sub>although the strongest immunostaining in this region is actually in the interneurons (<bold>i</bold>). <bold>C. </bold>The dentate cerebellar nucleus (<bold>dcn</bold>), displayed strong &#x003b3;<sub>2</sub> immunostaining in the cell bodies of this nucleus with only weak to moderate staining in the surrounding neuropil. In this particular section, cell nuclei are stained blue by Mayer's hematoxylin counterstain. <bold>D. </bold>Cerebellar folia displayed little to no &#x003b3;<sub>3</sub> immunostaining in the central white matter (<bold>wm</bold>) and molecular layer (<bold>m</bold>). Weak immunostaining was observed in the Purkinje cell bodies and the interneurons of the granule cell layer (<bold>g</bold>). <bold>E</bold>. Pre-absorption control, with the peptide immunogen for the &#x003b3;<sub>3</sub> Ab in the adjacent section to Fig. <bold>3D</bold>. <bold>F</bold>. The cell bodies of the Purkinje cells (<bold>p</bold>) stained strongly for &#x003b3;<sub>4</sub> and this extended well into the Purkinje cell dendrites (<bold>d</bold>). The surrounding molecular layer neuropil (<bold>m</bold>) displayed light-moderate staining, as did the granule cell layer (<bold>g</bold>). Cell bodies in the molecular layer immunoreactive to the &#x003b3;<sub>4</sub> Ab were small interneurons (<bold>i</bold>). <bold>G. </bold>Granule cell layer interneurons (<bold>i</bold>) stained much more strongly for &#x003b3;<sub>4 </sub>than the granule cells (<bold>g</bold>). <bold>H. </bold>The dcn gave a strong &#x003b3;<sub>4 </sub>immunostaining signal in the perisomatic neuropil with only weak staining in the nucleus cell bodies. <bold>I. </bold>Immunizing peptide pre-absorption control for the &#x003b3;<sub>2 </sub>Ab. Pre-absorption of the &#x003b3;<sub>3 </sub>or &#x003b3;<sub>4 </sub>Abs with their immunizing peptides produced almost identical results. Scale bars in all panels represent 25 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-4-23-3"></graphic></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>&#x003b3;<sub>2 </sub>immunohistochemistry in human hippocampus. </bold><bold>A. </bold>In the CA1, alveus (<bold>a</bold>), stratum oriens (<bold>o</bold>) most adjacent to the pyramidal layer, and the pyramidal layer (<bold>p</bold>) all stain moderately for &#x003b3;<sub>2</sub>. The stratum radiatum (<bold>r</bold>) and lacunosum-moleculare (<bold>l-m</bold>) stain much more weakly. <bold>B</bold>. Strong detection of &#x003b3;<sub>2 </sub>protein occurred in the alveus and pyramidal layers of CA2 and CA3 regions. Moderate immunostaining is detected in stratum lucidum (<bold>l</bold>). Staining of the strata oriens and radiatum was very weak in this region. The dentate gyrus molecular layer (<bold>ML</bold>) stains moderately for &#x003b3;<sub>2 </sub>and the granule layer strongly (<bold>GL</bold>). &#x003b3;<sub>2 </sub>staining is weak or absent in the polymorphic layer (<bold>PL</bold>). Cells in the CA4 show moderate staining. <bold>C and D</bold>. Serial sections to those displayed in panels <bold>A </bold>and <bold>B </bold>incubated with synthesis peptide pre-absorbed &#x003b3;<sub>2 </sub>Ab. <bold>E</bold>. In the region of the CA1 towards the CA2 the perisomatic staining is light to moderate with similar staining of the cell bodies. <bold>F</bold>. In the CA2, staining of neuropil and cell bodies is more intense than in CA1. <bold>G</bold>. Staining of the soma of the CA3 hippocampal neurons is strong with moderate staining of the surrounding neuropil. <bold>H</bold>. The dentate gyrus shows moderate staining of the molecular layer and dense immunostaining in the granule layer. The polymorphic layer is weakly stained. Scale bar in panels <bold>A&#x02013;D </bold>represents 250 &#x003bc;m, in panels <bold>E&#x02013;H</bold> 25 &#x003bc;m. The dotted lines in panels <bold>A </bold>and <bold>B </bold>represent the border between the CA4 region of the hippocampus and the polymorphic layer of the dentate gyrus.</p></caption><graphic xlink:href="1471-2202-4-23-4"></graphic></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>&#x003b3;<sub>3 </sub>immunohistochemistry in human hippocampus. </bold><bold>A. </bold>The pyramidal cell layer (<bold>p</bold>) of the CA1 region exhibited moderate to strong staining for &#x003b3;<sub>3</sub>. Weak staining was observed in the stratum oriens (<bold>o</bold>) and stratum radiatum (<bold>r</bold>). The alveus (<bold>a</bold>) and lacunosum-moleculare (<bold>l&#x02013;m</bold>) are in general, absent of immunoreactivity. <bold>B</bold>. More intense &#x003b3;<sub>3 </sub>immunostaining was observed in the CA2 and CA3 pyramidal cell layers than in CA1. Strong staining was also detected in CA4 cell bodies but surrounding neuropil is devoid of immunoreactivity. <bold>C and D</bold>. Sections adjacent to those displayed in panels <bold>A </bold>and <bold>B </bold>incubated with immunizing peptide-pre-absorbed &#x003b3;<sub>3 </sub>Ab. <bold>E</bold>. Moderate to strong staining of CA1 pyramidal cell bodies and weaker staining in the surrounding neuropil. <bold>F</bold>. Intense staining of the pyramidal cells of the CA3 with moderate perisomatic staining. <bold>G</bold>. Cell bodies in the subiculum (<bold>Sub</bold>) are moderately stained and neuropil staining is very weak. Neuropil staining in panels <bold>E</bold>, <bold>F </bold>and <bold>G </bold>may reflect relative cell densities in each region. <bold>H</bold>. Granule cells of the dentate gyrus were stained moderately to strongly by the &#x003b3;<sub>3 </sub>Ab. The immunoreactivity is mainly in the soma of these cells, but can also be seen in the early branches of the granule cells dendritic trees, which extend into the lightly stained molecular layer. The neuropil of the polymorphic layer is almost devoid of staining. Scale bars in panel <bold>A&#x02013;D </bold>represent 250 &#x003bc;m, in panels <bold>E&#x02013;H </bold>25 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-4-23-5"></graphic></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>&#x003b3;<sub>4 </sub>immunohistochemistry in human hippocampus. </bold><bold>A. </bold>&#x003b3;<sub>4 </sub>immunoreactivity was seen throughout the pyramidal cell layers each region of Ammon's horn and the surrounding neuropil with staining most intense in the CA2/3 transition region. Labeled regions are as in figures <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F5">5</xref> with the addition of subiculum (<bold>s</bold>) choroidal fissure (<bold>cf</bold>) and fimbria (<bold>f</bold>). <bold>B</bold>. Section adjacent to that in panel <bold>A </bold>incubated with immunizing peptide pre-absorbed &#x003b3;<sub>4 </sub>Ab. <bold>C</bold>. CA1 pyramidal cell bodies are moderately to strongly stained by &#x003b3;<sub>4 </sub>Ab with moderate staining in surrounding neuropil. <bold>D</bold>. Strong staining of pyramidal cells in the CA3 with only slightly weaker immunostaining in the neuropil. <bold>E</bold>. Staining of CA4 cell bodies is moderate to strong with moderate neuropil staining. <bold>F</bold>. Although positively stained, the granule neurons of the dentate gyrus do not stain as strongly for &#x003b3;<sub>4 </sub>as do pyramidal cells. Scale bars in panel <bold>A </bold>and <bold>B </bold>represent 5 mm and in panels <bold>C&#x02013;F </bold>25 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-4-23-6"></graphic></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Influence of &#x003b3;<sub>2 </sub>and &#x003b3;<sub>4 </sub>upon Ca<sub>V </sub>2.1/&#x003b2;<sub>4 </sub>&#x000b1; &#x003b1;2&#x003b4;<sub>2 </sub>VDCC currents expressed in <italic>Xenopus </italic>oocytes.</bold><bold>A </bold>The peak current-voltage relationships for Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>(n = 16), Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b3;<sub>2 </sub>(n = 14) and Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b3;<sub>4 </sub>(n = 11) show no significant differences in any parameters (Table <xref ref-type="table" rid="T1">1</xref>). The bottom panels display representative traces recorded from a single oocyte injected with each subunit combination investigated. <bold>B</bold>. The peak current-voltage relationships for Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>(n = 43), Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>2 </sub>(n = 34) and Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>4 </sub>(n = 20) show no significant differences in any parameters (Table <xref ref-type="table" rid="T1">1</xref>). In both panels <bold>A </bold>and <bold>B</bold>, only representative traces from -50 to +10 mV are displayed for reasons of clarity. <bold>C</bold>. Mean steady state inactivation data for I<sub>Ba </sub>recorded in 10 mM Ba<sup>2+ </sup>from <italic>Xenopus </italic>oocytes injected with Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>(n = 18) or Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;&#x003b3; (n = 18) <bold>D</bold>. Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>(n = 20), or Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>4 </sub>(n = 20). Co-expression of either &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4 </sub>produced data almost identical to the control. <bold>E</bold>. Oocytes injected with Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>(n = 22), Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>&#x003b3;<sub>2 </sub>(n = 16) and Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>&#x003b3;<sub>4 </sub>(n = 9) normalized to the maximum current I<sub>max </sub>and fitted with a single Boltzmann function. The numerical data for parameters defining the steady-state inactivation relationships are displayed in Table <xref ref-type="table" rid="T2">2</xref>.</p></caption><graphic xlink:href="1471-2202-4-23-7"></graphic></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Characteristics of I<sub>Ba </sub>via Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>or Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>with or without &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4</sub></p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left">Channel</td><td align="center" colspan="3">Activation</td><td></td><td align="left">n</td></tr><tr><td></td><td colspan="3"><hr></hr></td><td></td><td/></tr><tr><td></td><td align="left">V<sub>0.5act</sub>(mV)</td><td align="left">k<sub>act.</sub></td><td align="left">G<sub>max </sub>(&#x003bc;S)</td><td align="left">Peak at +10 mV (&#x003bc;A)</td><td></td></tr><tr><td colspan="5"><hr></hr></td><td/></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub></td><td align="left">-2.60 &#x000b1; 0.65</td><td align="left">5.39 &#x000b1; 0.49</td><td align="left">8.45 &#x000b1; 2.20</td><td align="left">-0.25 &#x000b1; 0.05</td><td align="left">16</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b3;<sub>2</sub></td><td align="left">-4.27 &#x000b1; 1.24</td><td align="left">4.91 &#x000b1; 0.52</td><td align="left">9.96 &#x000b1; 3.34</td><td align="left">-0.32 &#x000b1; 0.12</td><td align="left">14</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b3;<sub>4</sub></td><td align="left">-5.70 &#x000b1; 2.26</td><td align="left">5.43 &#x000b1; 0.47</td><td align="left">8.16 &#x000b1; 2.59</td><td align="left">-0.26 &#x000b1; 0.07</td><td align="left">11</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub></td><td align="left">-4.60 &#x000b1; 0.59</td><td align="left">4.03 &#x000b1; 0.15</td><td align="left">14.97 &#x000b1; 2.05 *</td><td align="left">-0.54 &#x000b1; 0.08</td><td align="left">43</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>2</sub></td><td align="left">-4.13 &#x000b1; 0.63</td><td align="left">4.46 &#x000b1; 0.14</td><td align="left">15.43 &#x000b1; 1.96</td><td align="left">-0.54 &#x000b1; 0.07</td><td align="left">34</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>4</sub></td><td align="left">-5.56 &#x000b1; 0.60</td><td align="left">3.96 &#x000b1; 0.24</td><td align="left">14.8 &#x000b1; 2.64</td><td align="left">-0.56 &#x000b1; 0.10</td><td align="left">20</td></tr></tbody></table><table-wrap-foot><p>To analyze the voltage-dependent activation, current-voltage (I-V) relationships (Figure <xref ref-type="fig" rid="F7">7A</xref> and Figure <xref ref-type="fig" rid="F7">7B</xref>) were fitted with a modified Boltzmann equation (see methods) to calculate V<sub>50act</sub>, the mid-point of voltage dependence of activation, k<sub>act</sub>, the slopefactor and G<sub>max</sub>, the maximum conductance. Values are expressed as mean &#x000b1; S. E. M. of the number of replicates, n. One-way analysis of variance (ANOVA) tests determined no statistically significant changes in any pairs of data differing by the presence of a &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4 </sub>P &#x0003c; 0.05 was considered significant). Statistically significant differences observed between the Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>and Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>channels are indicated by * (P &#x0003c; 0.05).</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Steady state inactivation properties of Ca<sub>V</sub>2.1/&#x003b2;<sub>4 </sub>or Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2 </sub>with or without &#x003b3;<sub>2 </sub>or &#x003b3;<sub>4</sub></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Channel</td><td align="center" colspan="2">Inactivation</td><td align="left">n</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td></tr><tr><td></td><td align="left">V<sub>50inact </sub>(mV)</td><td align="left">k<sub>inact</sub></td><td></td></tr></thead><tbody><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub></td><td align="left">-31.52 &#x000b1; 1.58</td><td align="left">7.04 &#x000b1; 0.19</td><td align="left">18</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>2</sub></td><td align="left">-33.44 &#x000b1; 1.49</td><td align="left">7.10 &#x000b1; 0.23</td><td align="left">18</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub></td><td align="left">-31.40 &#x000b1; 0.89</td><td align="left">7.04 &#x000b1; 0.28</td><td align="left">20</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b1;2&#x003b4;<sub>2</sub>/&#x003b3;<sub>4</sub></td><td align="left">-34.60 &#x000b1; 1.43</td><td align="left">6.61 &#x000b1; 0.28</td><td align="left">20</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub></td><td align="left">-32.40 &#x000b1; 1.09</td><td align="left">8.43 &#x000b1; 0.61</td><td align="left">22</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b3;<sub>2</sub></td><td align="left">-37.30 &#x000b1; 1.75</td><td align="left">7.52 &#x000b1; 0.74</td><td align="left">16</td></tr><tr><td align="left">Ca<sub>V</sub>2.1/&#x003b2;<sub>4</sub>/&#x003b3;<sub>4</sub></td><td align="left">-31.50 &#x000b1; 1.80</td><td align="left">8.40 &#x000b1; 0.92</td><td align="left">9</td></tr></tbody></table><table-wrap-foot><p>Steady-state inactivation data from Figures <xref ref-type="fig" rid="F7">7C, 7D</xref> and <xref ref-type="fig" rid="F7">7E</xref> were fitted with a single Boltzmann function (see methods). Values are expressed as mean &#x000b1; S. E. M. of the number of replicates, n. In the presence of an &#x003b1;2&#x003b4;<sub>2 </sub>subunit, neither &#x003b3;<sub>2 </sub>nor &#x003b3;<sub>4 </sub>caused statistically significant modulation of the measured parameters according to an un-paired Student's <italic>t</italic>-test (P &#x0003c; 0.05 was considered significant). Equally, when the &#x003b1;2&#x003b4;<sub>2 </sub>subunit was omitted from the injection mixture, ANOVA determined no statistically significant changes in any pairs of data differing by the presence of a &#x003b3; protein.</p></table-wrap-foot></table-wrap></sec></back></article> 